Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 2

Status

Recruiting 4Completed 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1

Conditions

Respiratory Aspiration 1Recurrence 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Intraoral Tumor 1Chalazion 1Carcinoma, Non-Small-Cell Lung 1Brain Edema 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Sevoflurane × 1 year × Clear all
NCT06330038 2026-04-20

GASTIVA

Samsung Medical Center

Phase 4 Recruiting
5,384 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT07450495 2026-03-04

SEVO-PED

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Phase NA Recruiting
80 enrolled

Chalazion

NCT06275087 2025-12-24

PSIOS

Clinical Hospital Centre Zagreb

Phase NA Recruiting
42 enrolled

Intraoral Tumor

NCT06779890 2025-10-01

TIVolBrain

Aristotle University Of Thessaloniki

Phase 4 Recruiting
84 enrolled

Brain Edema

NCT05343260 2025-07-31

Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery

Peking University First Hospital

Phase NA Completed
1,228 enrolled

Neoplasms, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡